UniProt ID | CDK5_HUMAN | |
---|---|---|
UniProt AC | Q00535 | |
Protein Name | Cyclin-dependent-like kinase 5 | |
Gene Name | CDK5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 292 | |
Subcellular Localization |
Isoform 1: Cytoplasm. Cell membrane Peripheral membrane protein. Perikaryon. Cell projection, lamellipodium. Cell projection, growth cone. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density. In axonal growth cone with extension |
|
Protein Description | Proline-directed serine/threonine-protein kinase essential for neuronal cell cycle arrest and differentiation and may be involved in apoptotic cell death in neuronal diseases by triggering abortive cell cycle re-entry. Interacts with D1 and D3-type G1 cyclins. Phosphorylates SRC, NOS3, VIM/vimentin, p35/CDK5R1, MEF2A, SIPA1L1, SH3GLB1, PXN, PAK1, MCAM/MUC18, SEPT5, SYN1, DNM1, AMPH, SYNJ1, CDK16, RAC1, RHOA, CDC42, TONEBP/NFAT5, MAPT/TAU, MAP1B, histone H1, p53/TP53, HDAC1, APEX1, PTK2/FAK1, huntingtin/HTT, ATM, MAP2, NEFH and NEFM. Regulates several neuronal development and physiological processes including neuronal survival, migration and differentiation, axonal and neurite growth, synaptogenesis, oligodendrocyte differentiation, synaptic plasticity and neurotransmission, by phosphorylating key proteins. Activated by interaction with CDK5R1 (p35) and CDK5R2 (p39), especially in post-mitotic neurons, and promotes CDK5R1 (p35) expression in an autostimulation loop. Phosphorylates many downstream substrates such as Rho and Ras family small GTPases (e.g. PAK1, RAC1, RHOA, CDC42) or microtubule-binding proteins (e.g. MAPT/TAU, MAP2, MAP1B), and modulates actin dynamics to regulate neurite growth and/or spine morphogenesis. Phosphorylates also exocytosis associated proteins such as MCAM/MUC18, SEPT5, SYN1, and CDK16/PCTAIRE1 as well as endocytosis associated proteins such as DNM1, AMPH and SYNJ1 at synaptic terminals. In the mature central nervous system (CNS), regulates neurotransmitter movements by phosphorylating substrates associated with neurotransmitter release and synapse plasticity; synaptic vesicle exocytosis, vesicles fusion with the presynaptic membrane, and endocytosis. Promotes cell survival by activating anti-apoptotic proteins BCL2 and STAT3, and negatively regulating of JNK3/MAPK10 activity. Phosphorylation of p53/TP53 in response to genotoxic and oxidative stresses enhances its stabilization by preventing ubiquitin ligase-mediated proteasomal degradation, and induces transactivation of p53/TP53 target genes, thus regulating apoptosis. Phosphorylation of p35/CDK5R1 enhances its stabilization by preventing calpain-mediated proteolysis producing p25/CDK5R1 and avoiding ubiquitin ligase-mediated proteasomal degradation. During aberrant cell-cycle activity and DNA damage, p25/CDK5 activity elicits cell-cycle activity and double-strand DNA breaks that precedes neuronal death by deregulating HDAC1. DNA damage triggered phosphorylation of huntingtin/HTT in nuclei of neurons protects neurons against polyglutamine expansion as well as DNA damage mediated toxicity. Phosphorylation of PXN reduces its interaction with PTK2/FAK1 in matrix-cell focal adhesions (MCFA) during oligodendrocytes (OLs) differentiation. Negative regulator of Wnt/beta-catenin signaling pathway. Activator of the GAIT (IFN-gamma-activated inhibitor of translation) pathway, which suppresses expression of a post-transcriptional regulon of proinflammatory genes in myeloid cells; phosphorylates the linker domain of glutamyl-prolyl tRNA synthetase (EPRS) in a IFN-gamma-dependent manner, the initial event in assembly of the GAIT complex. Phosphorylation of SH3GLB1 is required for autophagy induction in starved neurons. Phosphorylation of TONEBP/NFAT5 in response to osmotic stress mediates its rapid nuclear localization. MEF2 is inactivated by phosphorylation in nucleus in response to neurotoxin, thus leading to neuronal apoptosis. APEX1 AP-endodeoxyribonuclease is repressed by phosphorylation, resulting in accumulation of DNA damage and contributing to neuronal death. NOS3 phosphorylation down regulates NOS3-derived nitrite (NO) levels. SRC phosphorylation mediates its ubiquitin-dependent degradation and thus leads to cytoskeletal reorganization. May regulate endothelial cell migration and angiogenesis via the modulation of lamellipodia formation. Involved in dendritic spine morphogenesis by mediating the EFNA1-EPHA4 signaling. The complex p35/CDK5 participates in the regulation of the circadian clock by modulating the function of CLOCK protein: phosphorylates CLOCK at 'Thr-451' and 'Thr-461' and regulates the transcriptional activity of the CLOCK-ARNTL/BMAL1 heterodimer in association with altered stability and subcellular distribution.. | |
Protein Sequence | MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Ubiquitination | -----MQKYEKLEKI -----CCHHHHHHHC | 54.82 | - | |
4 | Phosphorylation | ----MQKYEKLEKIG ----CCHHHHHHHCC | 11.04 | 28978645 | |
6 | Acetylation | --MQKYEKLEKIGEG --CCHHHHHHHCCCC | 59.88 | 25953088 | |
9 | Acetylation | QKYEKLEKIGEGTYG CHHHHHHHCCCCCCC | 67.46 | 23954790 | |
9 | Malonylation | QKYEKLEKIGEGTYG CHHHHHHHCCCCCCC | 67.46 | 26320211 | |
9 | Ubiquitination | QKYEKLEKIGEGTYG CHHHHHHHCCCCCCC | 67.46 | - | |
9 | Sumoylation | QKYEKLEKIGEGTYG CHHHHHHHCCCCCCC | 67.46 | - | |
14 | Phosphorylation | LEKIGEGTYGTVFKA HHHCCCCCCCEEEEE | 17.93 | 21945579 | |
15 | Phosphorylation | EKIGEGTYGTVFKAK HHCCCCCCCEEEEEC | 22.96 | 22322096 | |
17 | Phosphorylation | IGEGTYGTVFKAKNR CCCCCCCEEEEECCC | 16.62 | 21945579 | |
20 | Ubiquitination | GTYGTVFKAKNRETH CCCCEEEEECCCCCE | 54.86 | - | |
20 | Acetylation | GTYGTVFKAKNRETH CCCCEEEEECCCCCE | 54.86 | 25953088 | |
20 | Methylation | GTYGTVFKAKNRETH CCCCEEEEECCCCCE | 54.86 | - | |
22 | Methylation | YGTVFKAKNRETHEI CCEEEEECCCCCEEE | 58.07 | - | |
22 | Ubiquitination | YGTVFKAKNRETHEI CCEEEEECCCCCEEE | 58.07 | - | |
33 | Acetylation | THEIVALKRVRLDDD CEEEEEEEEEECCCC | 38.83 | 25953088 | |
33 | Ubiquitination | THEIVALKRVRLDDD CEEEEEEEEEECCCC | 38.83 | - | |
46 | O-linked_Glycosylation | DDDEGVPSSALREIC CCCCCCCHHHHHHHH | 26.32 | 27316643 | |
46 | Phosphorylation | DDDEGVPSSALREIC CCCCCCCHHHHHHHH | 26.32 | 20873877 | |
47 | Phosphorylation | DDEGVPSSALREICL CCCCCCHHHHHHHHH | 25.83 | 20873877 | |
56 | Ubiquitination | LREICLLKELKHKNI HHHHHHHHHHCCCCE | 48.31 | 19608861 | |
56 | Acetylation | LREICLLKELKHKNI HHHHHHHHHHCCCCE | 48.31 | 19608861 | |
56 | Malonylation | LREICLLKELKHKNI HHHHHHHHHHCCCCE | 48.31 | 26320211 | |
72 | Phosphorylation | RLHDVLHSDKKLTLV EHHHHHCCCCCEEEE | 47.14 | 17192257 | |
74 | Ubiquitination | HDVLHSDKKLTLVFE HHHHCCCCCEEEEEE | 53.34 | - | |
74 | Acetylation | HDVLHSDKKLTLVFE HHHHCCCCCEEEEEE | 53.34 | 25953088 | |
75 | Ubiquitination | DVLHSDKKLTLVFEF HHHCCCCCEEEEEEE | 52.25 | - | |
88 | Ubiquitination | EFCDQDLKKYFDSCN EECCHHHHHHHHHCC | 54.43 | - | |
89 | Ubiquitination | FCDQDLKKYFDSCNG ECCHHHHHHHHHCCC | 59.45 | - | |
105 | Phosphorylation | LDPEIVKSFLFQLLK CCHHHHHHHHHHHHH | 19.11 | 21712546 | |
128 | Ubiquitination | NVLHRDLKPQNLLIN CCCCCCCCHHCEEEC | 49.17 | 21890473 | |
141 | Ubiquitination | INRNGELKLADFGLA ECCCCCEEEHHHHHH | 37.01 | 2190698 | |
158 | Phosphorylation | FGIPVRCYSAEVVTL HCCCEEEEEEEEEEE | 10.60 | 22817900 | |
159 | Phosphorylation | GIPVRCYSAEVVTLW CCCEEEEEEEEEEEE | 22.91 | 19276087 | |
167 | Phosphorylation | AEVVTLWYRPPDVLF EEEEEEEECCCCCCC | 19.16 | 18083107 | |
213 | Ubiquitination | NDVDDQLKRIFRLLG CCHHHHHHHHHHHHC | 37.50 | - | |
229 | Phosphorylation | PTEEQWPSMTKLPDY CCHHHCCCCCCCCCC | 35.80 | 27251275 | |
231 | Phosphorylation | EEQWPSMTKLPDYKP HHHCCCCCCCCCCCC | 33.49 | 20071362 | |
232 | Ubiquitination | EQWPSMTKLPDYKPY HHCCCCCCCCCCCCC | 49.75 | - | |
236 | Phosphorylation | SMTKLPDYKPYPMYP CCCCCCCCCCCCCCC | 16.36 | 20071362 | |
237 | Sumoylation | MTKLPDYKPYPMYPA CCCCCCCCCCCCCCC | 45.51 | - | |
237 | Ubiquitination | MTKLPDYKPYPMYPA CCCCCCCCCCCCCCC | 45.51 | - | |
239 | Phosphorylation | KLPDYKPYPMYPATT CCCCCCCCCCCCCCC | 9.11 | 22817900 | |
242 | Phosphorylation | DYKPYPMYPATTSLV CCCCCCCCCCCCHHH | 5.80 | 25884760 | |
245 | O-linked_Glycosylation | PYPMYPATTSLVNVV CCCCCCCCCHHHHHH | 16.65 | 27316643 | |
246 | O-linked_Glycosylation | YPMYPATTSLVNVVP CCCCCCCCHHHHHHH | 23.36 | 27316643 | |
247 | Phosphorylation | PMYPATTSLVNVVPK CCCCCCCHHHHHHHC | 26.43 | 28857561 | |
247 | O-linked_Glycosylation | PMYPATTSLVNVVPK CCCCCCCHHHHHHHC | 26.43 | 27316643 | |
254 | Ubiquitination | SLVNVVPKLNATGRD HHHHHHHCCCCCCHH | 42.64 | - | |
268 | Ubiquitination | DLLQNLLKCNPVQRI HHHHHHHCCCCCCCC | 34.82 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
15 | Y | Phosphorylation | Kinase | ABL1 | P00519 | Uniprot |
15 | Y | Phosphorylation | Kinase | EPHA4 | P54764 | Uniprot |
15 | Y | Phosphorylation | Kinase | FYN | P06241 | Uniprot |
15 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
47 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
77 | T | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
159 | S | Phosphorylation | Kinase | CSNK1A1 | P48729 | GPS |
159 | S | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
159 | S | Phosphorylation | Kinase | CK1_GROUP | - | PhosphoELM |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDK5_HUMAN !! |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-56, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; TYR-15; THR-17;SER-46; SER-72 AND TYR-239, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15; THR-17 AND SER-72,AND MASS SPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15, AND MASSSPECTROMETRY. |